SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody

OBJECTIVE: To determine whether an SRC homology 2 domain-containing phosphotyrosine phosphatase 2 (SHP2) inhibitor would increase muscle-specific kinase (MuSK) phosphorylation and override the inhibitory effect of MuSK-antibodies (Abs). METHODS: The effect of the SHP2 inhibitor NSC-87877 on MuSK pho...

Descripción completa

Detalles Bibliográficos
Autores principales: Huda, Saif, Cao, Michelangelo, De Rosa, Anna, Woodhall, Mark, Rodriguez Cruz, Pedro M., Cossins, Judith, Maestri, Michelangelo, Ricciardi, Roberta, Evoli, Amelia, Beeson, David, Vincent, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935836/
https://www.ncbi.nlm.nih.gov/pubmed/31831571
http://dx.doi.org/10.1212/NXI.0000000000000645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935836/
https://www.ncbi.nlm.nih.gov/pubmed/31831571
http://dx.doi.org/10.1212/NXI.0000000000000645

Ejemplares similares